Trotana Therapeutics
- Business Model
- B2B
- Website
- trotana.com
- Total Funding
- $52.5M
- Last Round
- $52.5M Series AFeb 2025
- Rounds
- 1
About
Biotechnology company developing RNA-based therapies and novel oral anti-inflammatory medicines.
Summary
Trotana Therapeutics is a Biotech company. It has raised $52.5M in total across 1 round, most recently a $52.5M Series A round in Feb 2025. Investors include Lightstone Ventures, ARCH Venture Partners and Andreessen Horowitz.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2025
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.